Aballe, Jonelou .

HRN: 28-88-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
AMPICILLIN 250MG (VIAL)
04/19/2026
04/26/2026
IV
215mg
Q6
PCAP C
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: